insights_auto
Why is PEB down 2.17%?
Dive Deeperchevron_right
PEB:ASX
Pacific Edge Ltd
A$0.22
arrow_downward
-2.17%(-0.0050) 1D
Nov 16, 4:00:00 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEB...
Open
A$0.23
High
A$0.23
Low
A$0.22
Mkt. cap
348.73M
Avg. vol.
54.06K
Volume
10.10K
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
Open
A$0.23
High
A$0.23
Low
A$0.22
Mkt. cap
348.73M
Avg. vol.
54.06K
Volume
10.10K
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
News stories
From web sources and news partners
marketscreener.com
·
17 minutes ago
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
Stocktwits
·
17 minutes ago
Morgan Stanley’s Mike Wilson Is Bullish On S&P 500 With A 15% Upside View For 2027
Benzinga
·
58 minutes ago
Forget Nvidia — S&P 500's 8,900 Target Puts These ETFs in Play - State Street SPDR S&P 500 ETF Trust (ARC
BigGo Finance
·
3 hours ago
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
Profile
Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the Australian ASX and the New Zealand NZX main board stock exchange. Wikipedia
About Pacific Edge Ltd
CEO-
Employees114
Founded2001
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitepacificedgedx.com